
Recordati Rare Diseases, Inc. (RRD) develops high-impact therapies for rare diseases, focusing on providing treatments to underserved communities in the U.S.
The Medical Science Liaison will foster collaborative relationships with opinion leaders focused on Cold Agglutinin Disease (CAD) and facilitate the exchange of unbiased scientific information between the medical community and the company.
Recordati Rare Diseases, Inc. (RRD) develops high-impact therapies for rare diseases, focusing on providing treatments to underserved communities in the U.S.